Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis C Virus
Hepatitis C virus-positive liver transplant patients may not benefit from treatment withdrawal
October 5th, 2006
According to a study from Germany, hepatitis C virus (HCV)-positive liver transplant patients may not benefit from treatment withdrawal. "The aim of this study was to evaluate the clinical long-term consequences of antiviral treatment discontinuation in viremic hepatitis C virus (HCV)-positive liver transplant recipients," wrote A. Kornberg and colleagues, University of Jena. "Twenty-five HCV-positive patients after liver transplantation were included in this study. After diagnosing recurrent hepatitis C, a combination therapy with interferon-alpha 2b and ribavirin for a minimum of 12 months was initiated. "Viremia levels and...
Source: Blood Weekly (2006-10-05)
|
